Huayining® Glipizide Tablets is a second-generation sulfonylurea oral hypoglycemic drug. It can promote the secretion of insulin by pancreatic islet β cells and enhance the effect of insulin on target tissues; It can also stimulate pancreatic islet A cells to inhibit glucagon secretion, inhibit liver glycogen decomposition, promote muscle utilization and glucose consumption.
Primary Indications
For type II diabetes
The Main Contraindication To Medication
1. Type I diabetes, diabetic ketosis, diabetic precoma or coma phase.
2. Liver insufficiency, adrenal insufficiency and allergies to this product are prohibited.
Tablets